Phibro Animal Health Corporation Asset Resilience Ratio
Phibro Animal Health Corporation asset resilience ratio. Phibro Animal Health Corporation (PAHC) has an Asset Resilience Ratio of 1.37% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PAHC days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Phibro Animal Health Corporation (2014–2026)
Asset resilience ratio of Phibro Animal Health Corporation from 2014 to 2026. This chart shows how Phibro Animal Health Corporation's Asset Resilience Ratio has changed over time. Read how much debt does Phibro Animal Health Corporation carry for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Phibro Animal Health Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PAHC current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $20.57 Million | 1.37% |
| Total Liquid Assets | $20.57 Million | 1.37% |
Asset Resilience Insights
- Limited Liquidity: Phibro Animal Health Corporation maintains only 1.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Phibro Animal Health Corporation Industry Peers by Asset Resilience Ratio
Compare Phibro Animal Health Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
Phibro Animal Health Corporation Asset Resilience Ratio by Year (2014–2026)
Phibro Animal Health Corporation asset resilience ratio by year from 2014 to 2026. The table below shows the annual Asset Resilience Ratio data for Phibro Animal Health Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-06-30 | 1.37% | $20.57 Million | $1.50 Billion | +0.71pp |
| 2025-06-30 | 0.66% | $9.00 Million | $1.36 Billion | -3.82pp |
| 2024-06-30 | 4.48% | $44.00 Million | $982.18 Million | +0.36pp |
| 2023-06-30 | 4.12% | $40.00 Million | $971.40 Million | +2.29pp |
| 2022-06-30 | 1.82% | $17.00 Million | $931.70 Million | -3.29pp |
| 2021-06-30 | 5.11% | $43.00 Million | $841.33 Million | -1.90pp |
| 2020-06-30 | 7.01% | $55.00 Million | $784.10 Million | +3.71pp |
| 2019-06-30 | 3.30% | $24.00 Million | $726.67 Million | -4.14pp |
| 2018-06-30 | 7.44% | $50.00 Million | $671.68 Million | +7.01pp |
| 2017-06-30 | 0.43% | $2.69 Million | $623.40 Million | -0.07pp |
| 2016-06-30 | 0.50% | $3.03 Million | $610.37 Million | -- |
| 2015-06-30 | 0.00% | $0.00 | $493.32 Million | -- |
| 2014-06-30 | 0.00% | $0.00 | $472.32 Million | -- |
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including po… Read more